I have been a writer for my entire life, and my first foray into journalism was writing for a student-led zine founded on social media. I now have experience with traditional news reporting, magazine writing, opinion columns, newsletters, and editing. I also shaped communications for student clubs and research organizations, edited podcasts, and produced visual content.
You can check out a selection of my work by clicking the descriptors in each box below; a blue pop-up window should appear. Use the buttons to filter by categories.
If you are having trouble viewing the pop-ups on a mobile device, try rotating your screen.
The death of Danny Lee Winstead: a Duke public safety shooting and its aftermath
In summer 2020, the Duke Black Coalition Against Policing issued a list of demands regarding the Duke University Police Department. This sparked The Chronicle to review previous incidents in which DUPD used lethal force, including the 1982 shooting death of Danny Winstead. I reviewed The Chronicle's previous coverage of the incident, coverage in other Durham news outlets, and records from the Office of the Chief Medical Examiner. I also reached out to Winstead's family members.
In 2021, the state of North Carolina entered a settlement with Juul Labs, Inc. following a lawsuit over its impact on minors. That settlement involved years of scheduled payments to the state to be used for vaping cessation efforts. For this story, I followed up on whether the state had been receiving its payments, how that money was being used, and whether other provisions of the settlement were being met. Reporting primarily relied on interviews, the state's biennial budget, state finance data, and settlement documents.
This article was also published in The News & Observer and the Herald-Sun.
I learned about ghost networks through my health policy studies, and as an investigative intern with McClatchy I sought to understand the extent of the problem in North Carolina. For this story, I manually verified about 50 listings in Blue Cross and Blue Shield's directory; spoke with the insurance company, researchers, providers and residents; and reviewed complaints from the N.C. Department of Insurance.
A follow-up story highlighting a resident's efforts to locate an urgent care facility that accepted his insurance was published Aug. 15, 2022. See my research page to see the poster I presented at the 2022 Duke-Margolis retreat on this story's findings.
This article was also published in The News & Observer and the Herald-Sun. A portion of the article was included in the NC Insider newsletter.
At Duke, I wrote newsletters for The Chronicle and the Student Collaborative on Health Policy. This involved summarizing recent news and upcoming events, as well as using creative voice to keep readers engaged.
McClatchy's North Carolina newsrooms work on reporting projects called ReImagines, in which they go in-depth on a specific topic. In summer 2022, we began working on a ReImagine examining the impact of gun violence on Charlotte-area youth.
In the early stages of the project, I began compiling a spreadsheet of incidents in which minors were shot using news reports, the national Gun Violence Archive, and Charlotte open data. What was intended to be an internal resource for the reporting team eventually became its own story, especially because of the challenges in identifying non-fatal shootings.
I also interviewed psychologists on the emotional toll of violence, as well as people involved with the Mecklenburg County Child Development-Community Policing program, a partnership between social workers and law enforcement that aims to intervene when children witness a traumatic event.
How Immigration Policy Changes Can Affect Biopharma Hiring
BioSpace, Feb. 14, 2024 Is this link broken/unresponsive? Try the Wayback Machine or contact me.
I spent multiple weeks examining data, policies, and research surrounding pathways for international students and workers to secure biopharma jobs in the U.S.
Rare Disease Drug Development Urgently Needs More Funding, Experts Say
BioSpace, Feb. 28, 2024 Is this link broken/unresponsive? Try the Wayback Machine or contact me.
I explored current investments in rare disease research and development and interviewed patient advocates about what needs to be done to bring these drugs to market.
In May 2020, I had an excisional biopsy for a five-centimeter breast tumor. Although the tumor ended up being benign, the experience was an eye-opener; both for my knowledge about breast health and how care delivery can easily be disrupted. This essay describes that experience.
A follow-up to Navigating My Care in a Pandemic, this essay describes what I've come to learn about benign breast disease in the years since my first tumor - and what researchers still don't know. This piece features interviews and data from the U.S. Medical Expenditures Panel Survey and National Ambulatory Medical Care Survey.
As a researcher and later media engagement lead with the Social Mission Alliance, I published an op-ed in NC Newsline describing the importance of financial aid in supporting students from underrepresented backgrounds and maintained a newsletter containing stories and opportunities for over 200 health professions students. I also evaluated opinion pitches from health professions students and workers, established guidelines for publication, and provided feedback on submissions.
Is this link broken/unresponsive? The op-ed is also available on the SMA website. Otherwise, try the Wayback Machine or contact me.